News
Zacks.com on MSN20m
Merck's Narrowed 2025 Sales View: What it Means After Q2 Results?MRK trims its 2025 sales range but lifts the lower end of its EPS outlook. Keytruda, Animal Health and new drugs are expected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback